We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56 (ELEVATE-TIMI56)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01235351
Recruitment Status : Unknown
Verified October 2011 by The TIMI Study Group.
Recruitment status was:  Active, not recruiting
First Posted : November 5, 2010
Last Update Posted : October 5, 2011
Bristol-Myers Squibb
Information provided by:
The TIMI Study Group

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2011
  Study Completion Date : No date given

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 December 7, 2012 January 14, 2013
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):